T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 16, Issue 12, Pages 1145-1149
Publisher
Informa Healthcare
Online
2012-09-22
DOI
10.1517/14728222.2012.726616
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells
- (2012) R. G. Veenstra et al. BLOOD
- Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner
- (2012) Souichi Oomizu et al. CLINICAL IMMUNOLOGY
- IL-33: a promising therapeutic target for rheumatoid arthritis?
- (2011) Feng-Lai Yuan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Underexpression of TIM-3 and Blunted Galectin-9-Induced Apoptosis of CD4+ T Cells in Rheumatoid Arthritis
- (2011) Jaejoon Lee et al. INFLAMMATION
- The −1541 C>T and +4259 G>T of TIM-3 polymorphisms are associated with rheumatoid arthritis susceptibility in a Chinese Hui population
- (2011) J. Xu et al. International Journal of Immunogenetics
- Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis
- (2011) J Lee et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Rheumatoid arthritis in women: Incidence rates in group health cooperative, seattle, washington, 1987-1989
- (2010) Carin E. Dugowson et al. ARTHRITIS AND RHEUMATISM
- The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis
- (2010) Xia Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity
- (2010) Ying Liu et al. CLINICAL IMMUNOLOGY
- Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis
- (2010) Kazuki Sakai et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- TIM-3: A Novel Regulatory Molecule of Alloimmune Activation
- (2010) O. Boenisch et al. JOURNAL OF IMMUNOLOGY
- Galectin-9 ameliorates immune complex-induced arthritis by regulating FcγR expression on macrophages
- (2009) Tomohiro Arikawa et al. CLINICAL IMMUNOLOGY
- TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
- (2009) William D. Hastings et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The costimulatory role of TIM molecules
- (2009) Roselynn Rodriguez-Manzanet et al. IMMUNOLOGICAL REVIEWS
- TIM-3 as a new therapeutic target in systemic lupus erythematosus
- (2009) Hai-Feng Pan et al. MOLECULAR BIOLOGY REPORTS
- Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
- (2008) Masako Seki et al. CLINICAL IMMUNOLOGY
- TIM-1 and TIM-3 proteins in immune regulation
- (2008) Ee Wern Su et al. CYTOKINE
- Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
- (2008) R. Brad Jones et al. JOURNAL OF EXPERIMENTAL MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started